foundationmedicine.co.uk Report : Visit Site

Technical data of the foundationmedicine.co.uk

Geo IP provides you such as latitude, longitude and ISP (Internet Service Provider) etc. informations. Our GeoIP service found where is host foundationmedicine.co.uk. Currently, hosted in Germany and its service provider is TWL-Kom GmbH .

the related websites

st-andrews.ac.uk getintomedicine.co.uk foundationprogramme.nhs.uk medschools.ac.uk bradford.ac.uk studyin-uk.com exeter.ac.uk bmh.manchester.ac.uk ppu.mrc.ac.uk jobs.nhs.uk ets.org katiemelua.com shaunthesheep.com nhm.ac.uk antonygormley.com channel4.com dolcegabbana.com placeboworld.co.uk raspberrypi.org 

HTTP Header Analysis

HTTP Header information is a part of HTTP protocol that a user's browser sends to called Apache/2.4.7 (Ubuntu) containing the details of what the browser wants and will accept back from the web server.

DNS

HtmlToText

genomic profiling order learn more about us deutschland schweiz österreich foundationone® cdx phone email order fax welcome to foundation medicine foundation medicine is intended for uk healthcare professionals only. by entering this site you are confirming that you are a uk healthcare professional i am a healthcare professional i am a member of the public roche is pleased to announce the launch of foundationone® cdx. as of the 1st november 2018 foundationone® cdx will replace foundationone, our original tissue based test for solid tumours. foundationone® cdx has an updated gene list to capture the most clinically relevant genomic alterations found in solid tumours and an improved report listing european medicines agency (ema) approved therapies and local clinical trials. about genomic profiling what is foundationone® cdx ? foundationone® cdx provides a comprehensive genomic profile to identify molecular alterations in a patient's cancer and match them with targeted therapies and clinical trials to support decision making by multi-disciplinary teams. weitere informationen -- who is it suitable for? who is suitable for the foundationone® cdx tumour profiling service? foundationone® cdx is suitable for most patients with malignant solid tumour cancers. it is most frequently used in patients with advanced, recurrent and / or metastatic cancers who have exhausted standard of care treatment options. foundationone® cdx reports reveal clinically relevant alterations in tumour dna that are associated with the effect of targeted cancer treatments either documented in the existing clinical literature or that are being explored in clinical studies. this service is not designed to predict response to chemotherapy or recurrence. ordering foundationone® cdx how the process works: the oncologist orders foundationone® cdx from roche the pathologist prepares tumour sample pathologist sends the sample to foundation medicine foundation medicine analyse the tumour sample and produce a clinical report containing the results the clinical report is sent from foundation medicine to the oncologist via a secure portal for oncologists getting started: please download the order form, complete all of the information requested. sign and send with a valid purchase order from your organisation to [email protected] or freefax 0800 917 8307. you will be required to confirm that you will either (i) use the informed consent form provided or (ii) warrant that existing consent form(s) appropriately obtain the consent as detailed in our informed consent form, with particular regard to the exchange of personal and/or sensitive personal data beyond the eu and/or eea. do not send the informed consent form to roche or foundation medicine download order & informed consent form download link to pathology and oncology information pack your next steps for pathologists getting started foundationone requires 40\0x03bcm of ffpe tissue, of which approx 20% or more is of malignant origin, on 8 to 10 unstained slides or from a block reviewed and approved by a pathologist as the most representative block for the patient diagnosis. all solid tumour types are acceptable. foundation medicine is able to process any clinical sample that meets these guidelines. should your sample be insufficient, you will be notified as soon as possible following reciept. if you have a question about the order process, collection or the status of your order, please contact the roche foundation medicine customer care team on 0800 731 5711 or by e-mail [email protected] . if you have a question about the sample please contact the medical information team on 0800 328 1629 or email [email protected] . requisition form -- your next steps learn more contact us for more information about the ordering process contact the roche foundation medicine customer care team: freephone: 0800 731 5711 e-mail: [email protected] fax: +41 61 715 44 02 -- for technical and scientific enquiries related to the foundation medicine service please contact the medical information team on: 0800 328 1629 e-mail: [email protected] faq for healthcare professionals who is suitable for the foundationone® cdx service? foundationone® cdx is suitable for most patients with malignant solid tumour cancers. it is most frequently used in patients with advanced, recurrent and / or metastatic cancers who have exhausted standard of care treatment options. foundationone® cdx reports reveal clinically relevant alterations in tumour dna that are associated with the effect of targeted cancer treatments either documented in the existing clinical literature or that are being explored in clinical studies. what are the specimen requirements for foundationone® cdx? foundationone® cdx requires 40 \0x03bcm of ffpe tissue, of which approx 20% or more is of malignant origin, on 8 to 10 unstained slides or from a block reviewed and approved by a pathologist as the most representative block for the patient diagnosis. all solid tumour types are acceptable. click here to download detailed specimen guidelines. foundation medicine is able to process any clinical sample that meets these guidelines. should your sample be insufficient or unsatisfactory you will be notified as soon as possible following receipt. how long does it take to get results? the ordering oncologist will receive a report approximately 11 to 14 days after foundation medicine receives a satisfactory tissue sample. how do i obtain the results? we will send the results via your foundation online account. you are solely responsible for any and all action(s) undertaken as a result of the information provided in the foundationone® cdx and/or foundationone heme® report(s) (“report”) and roche does not seek to recommend any particular medication(s) referred therein. it is your responsibility to evaluate and interpret the information provided in the report, along with all other available clinical information regarding your patient, in order to determine the best treatment decision(s) in your own independent medical judgment, and as far as possible in collaboration with other healthcare professionals involved in the care of your patient. does this service predict response to chemotherapy or the likelihood of recurrence? no, this service is not designed to predict response to chemotherapy or recurrence. the service helps match the genomic alterations present in a tumour with specific targeted therapies or clinical trials. what information does the foundationone® cdx service provide? foundationone® cdx may identify an "actionable" mutation(s) helping: 1. identify an ema approved therapy for the patient's tumour type and shown to target one or more of the genomic alterations found by the service, 2. identify an ema approved therapy in another tumour type and shown to target one or more of the genomic alterations found by the service, or 3. identify clinical trials of a licensed or experimental treatment which may work by targeting an alteration found by the service or a relevant pathway. will another biopsy need to be taken for the service? a recent sample of a patient’s tumour is preferred as genomic alterations are known to change over time and with treatment. the service can be run on a tissue sample from an earlier biopsy of either the primary tumour or cancer cells that have spread to other parts of the body. if there is not enough tissue remaining from an earlier biopsy to run the service an additional biopsy may need to be collected. it may be required to take a new biopsy to get a more recent sample. does it matter what kind of cancer a patient presents with or how advanced the cancer is? foundationone® cdx is designed to profile any type of tumour regardless of where it is found in the body or how advanced the cancer. however, the service is generally used for more advanced disease or disease that has spread. are the results intende

URL analysis for foundationmedicine.co.uk

http://www.foundationmedicine.co.uk///fileadmin/websites/co.uk/10_18/download_pack.zip
http://www.foundationmedicine.co.uk//#content-137
http://www.foundationmedicine.co.uk//#content-134
http://www.foundationmedicine.co.uk//#content-135
http://www.foundationmedicine.co.uk///fileadmin/websites/co.uk/10_18/rxukrfmi0001b_3__consent_form_v1__1__09_10_18.pdf
http://www.foundationmedicine.co.uk//mailto:[email protected]
http://www.foundationmedicine.co.uk///fileadmin/websites/co.uk/10_18/rxukrfmi00001a_5_roche_foundation_medicine_order_and_informed_consent_form_uk_final_version.pdf
http://www.foundationmedicine.co.uk///fileadmin/websites/co.uk/10_18/rxukrfmi00001e_2__technical_specifications_final2__23_10_18.pdf
http://www.foundationmedicine.co.uk//mailto:[email protected]
http://www.foundationmedicine.co.uk//#order
http://www.foundationmedicine.co.uk//#genomic_profiling
http://www.foundationmedicine.co.uk//#tab-3-4
http://www.foundationmedicine.co.uk///fileadmin/websites/co.uk/10_18/rxukrfmi00001d_1__rochefoundationmedicinespeciminguideline_v6__5__17_10_18.pdf
http://www.foundationmedicine.co.uk//#tab-3-1
http://www.foundationmedicine.co.uk//tel:08009178307
roche.co.uk

Whois Information

Whois is a protocol that is access to registering information. You can reach when the website was registered, when it will be expire, what is contact details of the site with the following informations. In a nutshell, it includes these informations;

Domain name:
foundationmedicine.co.uk

Registrant:
F. Hoffmann-La Roche AG

Registrant type:
Unknown

Registrant's address:
Konzern-Hauptsitz
Grenzacherstrasse 124
Basel
Basel-Stadt
4070
Switzerland

Data validation:
Nominet was able to match the registrant's name and address against a 3rd party data source on 18-Feb-2016

Registrar:
Safenames Ltd [Tag = SAFENAMES]
URL: http://www.safenames.net

Relevant dates:
Registered on: 01-Mar-2017
Expiry date: 01-Mar-2019
Last updated: 01-Mar-2017

Registration status:
Registered until expiry date.

Name servers:
hlrns1.roche.com
ns1.roche.com
ns2.roche.com

WHOIS lookup made at 15:22:43 03-May-2018

--
This WHOIS information is provided for free by Nominet UK the central registry
for .uk domain names. This information and the .uk WHOIS are:

Copyright Nominet UK 1996 - 2018.

You may not access the .uk WHOIS or use any data from it except as permitted
by the terms of use available in full at http://www.nominet.uk/whoisterms,
which includes restrictions on: (A) use of the data for advertising, or its
repackaging, recompilation, redistribution or reuse (B) obscuring, removing
or hiding any or all of this notice and (C) exceeding query rate or volume
limits. The data is provided on an 'as-is' basis and may lag behind the
register. Access may be withdrawn or restricted at any time.

  REFERRER http://www.nominet.org.uk

  REGISTRAR Nominet UK

SERVERS

  SERVER co.uk.whois-servers.net

  ARGS foundationmedicine.co.uk

  PORT 43

  TYPE domain

OWNER

  ORGANIZATION F. Hoffmann-La Roche AG

TYPE
Unknown

ADDRESS
Konzern-Hauptsitz
Grenzacherstrasse 124
Basel
Basel-Stadt
4070
Switzerland
Data validation:
Nominet was able to match the registrant's name and address against a 3rd party data source on 18-Feb-2016

DOMAIN

  SPONSOR Safenames Ltd [Tag = SAFENAMES]

  CREATED 2017-03-01

  CHANGED 2017-03-01

STATUS
Registered until expiry date.

NSERVER

  HLRNS1.ROCHE.COM 206.53.227.33

  NS1.ROCHE.COM 196.3.50.135

  NS2.ROCHE.COM 196.3.46.25

  NAME foundationmedicine.co.uk

DISCLAIMER
This WHOIS information is provided for free by Nominet UK the central registry
for .uk domain names. This information and the .uk WHOIS are:
Copyright Nominet UK 1996 - 2018.
You may not access the .uk WHOIS or use any data from it except as permitted
by the terms of use available in full at http://www.nominet.uk/whoisterms,
which includes restrictions on: (A) use of the data for advertising, or its
repackaging, recompilation, redistribution or reuse (B) obscuring, removing
or hiding any or all of this notice and (C) exceeding query rate or volume
limits. The data is provided on an 'as-is' basis and may lag behind the
register. Access may be withdrawn or restricted at any time.

  REGISTERED yes

Mistakes

The following list shows you to spelling mistakes possible of the internet users for the website searched .